Reduced Platelet Activity is More Common than Reported Anti-Platelet Medication Use in Patients with Intracerebral Hemorrhage
Andrew M. Naidech(American Heart Association), Thomas P. Bleck(Northwestern University), Sarice L. Bassin, H. Hunt Batjer(The University of Texas Southwestern Medical Center), Mark J. Alberts(Nanotherapeutics (United States)), Paul F. Lindholm, Richard A. Bernstein(Northwestern University)
Cited by 30
Related Papers
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
|Neurology|1993|3.8k
Cryptogenic Stroke and Underlying Atrial Fibrillation
|New England Journal of Medicine|2014|2.2k
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
|Stroke|2006|1.9k
Guidelines for the Evaluation and Management of Status Epilepticus
|Neurocritical Care|2012|1.6k
Idarucizumab for Dabigatran Reversal — Full Cohort Analysis
|New England Journal of Medicine|2017|1.1k